Skip Ribbon Commands
Skip to main content
ORF Home > Construction > ORF Signature Projects > Vaccine Research Center Laboratory Expansion, Building 40A (North Tower)

Vaccine Research Center Laboratory Expansion, Building 40A (North Tower)

​Vaccine Research Center Laboratory Expansion, Building 40A North Tower  Rendering and Work Site


 Building 40A will be a six story, 158,141 gross square foot addition to the Building 40 NIAID Vaccine Research Center (VRC).  Building 40A will double the available laboratory space of the VRC, and it will house BSL-2 and specialty laboratories, laboratory support space, administrative support space and conference/meeting rooms.  The VRC is in the forefront of developing vaccines for infectious disease threats, including coronaviruses (SARS-CoV-2, MERS-CoV, SARS-CoV), influenza, HIV/AIDS and Ebola.  The VRC is frequently called upon to address biodefense threats and global pandemic emerging infectious disease threats.  


Project Officer: Maya M. Kai Kai
Support: James Cameron, Melinda Alexander, Dhanika Ranasinghe, Chuck Boehmer
Cost: $197M
Completion: September 2024



 
This page was last updated on Oct 03, 2022